Non-regenerative anemia, which is characterized by an inadequate production of new red blood cells, is a frequent and serious complication of kidney failure, certain forms of cancer or cancer therapy, and other chronic diseases. These investigators have developed a new synthesized form of feline erythropoietin, a red blood cell stimulating hormone. The human form of this hormone has been available for more than a decade, but is not safe to use in the cat. This study will assess the bioactivity of this new therapy in the laboratory and in cats with non-regenerative anemia.
Grants